Acute Urticaria: Symptoms, Causes, and Evaluation of Phenotypes Prone to Chronicity
International Archives of Allergy and Immunology · 10.07.2024 · 185 (12) · 1216-1225
DOI: 10.1159/000538903 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, online erschienen am 10.07.2024. Verfasst von Begum Gorgulu Akin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Allergy, Ankara Bilkent City Hospital, Ankara, Turkey, drbegumgorgulu@gmail.com. Hauptthemen laut MEDLINE: Urticaria, Chronic Urticaria, Phenotype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
Urticaria is a condition that is characterized by the development of wheals (hives), angioedema, or both. If symptoms persist for less than 6 weeks, it is classified as acute urticaria (AU), and if they persist for longer than 6 weeks, it is classified as chronic urticaria (CU). Disease activity is evaluated using validated patient-reported outcome measures (PROMs) such as the 7-day urticaria activity score (UAS-7) and urticaria control test (UCT). In this study, we aimed to determine whether there was a difference between patients with chronic and recovered urticaria in terms of age, sex, symptoms, disease severity, disease control, and triggering factors by following patients with AU for 6 months.
Methods
The routine tests were requested at the first admission of the patients. If previously examined, anti-thyroid peroxidase (anti-TPO), anti-nuclear antibody, etc., were recorded. After the first examination, the patients were evaluated again using a visual analog scale (VAS), UCT, UAS-7, and medication scores (MSs) in the 1st, 3rd, and 6th months.
Results
One hundred nine (F/M: 80/29) patients were included in the study. Twenty-seven patients had a previous history of AU, 22 of these patients were evaluated as having recurrent AU, and five became chronic during follow-up. Urticaria continued in 22 of 82 patients who presented with first-attack AU in the 3rd month and 17 in the 6th month. We had a chronicity rate of 24.7%. It was determined that having positive anti-TPO increased the risk of CU 1.69 times. A statistically significant improvement was found in the mean VAS, UCT, UAS-7, and MSs evaluated in the 1st, 3rd, and 6th months of patients with CU compared with baseline.
Conclusion
AU is a common disease and usually heals in a short time without becoming chronic. Studies on the causes of chronicity are limited. Testing anti-TPO in patients presenting with AU may be useful in terms of disease course and risk of chronicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunology and Allergy, Ankara Bilkent City Hospital, Ankara, Turkey, drbegumgorgulu@gmail.com.
- Immunology and Allergy, Ankara Bilkent City Hospital, Ankara, Turkey.
- Division of Immunology and Allergy, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
Zitieren
APA
Gorgulu Akin, B., Beyaz, S., & Celebi Sozener, Z. (2024). Acute Urticaria: Symptoms, Causes, and Evaluation of Phenotypes Prone to Chronicity. International Archives of Allergy and Immunology, 185(12), 1216-1225. https://doi.org/10.1159/000538903
Vancouver
Gorgulu Akin B, Beyaz S, Celebi Sozener Z. Acute Urticaria: Symptoms, Causes, and Evaluation of Phenotypes Prone to Chronicity. International Archives of Allergy and Immunology. 2024;185(12):1216-1225. doi:10.1159/000538903
BibTeX
@article{GorguluAkin2024,
author = {Gorgulu Akin, Begum and Beyaz, Sengul and Celebi Sozener, Zeynep},
title = {Acute Urticaria: Symptoms, Causes, and Evaluation of Phenotypes Prone to Chronicity},
journal = {International Archives of Allergy and Immunology},
year = {2024},
volume = {185},
number = {12},
pages = {1216--1225},
doi = {10.1159/000538903}
}
EUVIMED